Review



human bone marrow mesenchymal stem cells hbmscs  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC human bone marrow mesenchymal stem cells hbmscs
    Interaction between DLX6-AS1 and miR-141-3p. A Predicted target sites. B Dual-luciferase reporter validation of the interaction. C Correlation analysis of serum DLX6-AS1 and miR-141-3p levels. D , E Expression of chondrogenic differentiation markers D , DLX6-AS1, and miR-141-3p E during <t>hBMSCs</t> chondrogenic differentiation. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow <t>mesenchymal</t> stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001
    Human Bone Marrow Mesenchymal Stem Cells Hbmscs, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 772 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone marrow mesenchymal stem cells hbmscs/product/ATCC
    Average 96 stars, based on 772 article reviews
    human bone marrow mesenchymal stem cells hbmscs - by Bioz Stars, 2026-02
    96/100 stars

    Images

    1) Product Images from "Serum DLX6-AS1 and miR-141-3p as early diagnostic biomarkers and regulators of delayed fracture healing (DFH)"

    Article Title: Serum DLX6-AS1 and miR-141-3p as early diagnostic biomarkers and regulators of delayed fracture healing (DFH)

    Journal: Journal of Orthopaedic Surgery and Research

    doi: 10.1186/s13018-025-06478-5

    Interaction between DLX6-AS1 and miR-141-3p. A Predicted target sites. B Dual-luciferase reporter validation of the interaction. C Correlation analysis of serum DLX6-AS1 and miR-141-3p levels. D , E Expression of chondrogenic differentiation markers D , DLX6-AS1, and miR-141-3p E during hBMSCs chondrogenic differentiation. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow mesenchymal stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001
    Figure Legend Snippet: Interaction between DLX6-AS1 and miR-141-3p. A Predicted target sites. B Dual-luciferase reporter validation of the interaction. C Correlation analysis of serum DLX6-AS1 and miR-141-3p levels. D , E Expression of chondrogenic differentiation markers D , DLX6-AS1, and miR-141-3p E during hBMSCs chondrogenic differentiation. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow mesenchymal stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001

    Techniques Used: Luciferase, Biomarker Discovery, Expressing

    Effect of DLX6-AS1/miR-141-3p on hBMSCs functions. A qRT-PCR analysis of DLX6-AS1 and miR-141-3p after si-DLX6-AS1 treatment with or without miR-inhibition. B Proliferation level. C Apoptosis rate. D Expression of chondrogenic differentiation markers SOX9, COL2A1, and ACAN. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow mesenchymal stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001
    Figure Legend Snippet: Effect of DLX6-AS1/miR-141-3p on hBMSCs functions. A qRT-PCR analysis of DLX6-AS1 and miR-141-3p after si-DLX6-AS1 treatment with or without miR-inhibition. B Proliferation level. C Apoptosis rate. D Expression of chondrogenic differentiation markers SOX9, COL2A1, and ACAN. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow mesenchymal stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001

    Techniques Used: Quantitative RT-PCR, Inhibition, Expressing

    VEGFA is a binding target of miR-141-3p. A Predicted binding sequence. B Dual-luciferase assay validation. C VEGFA expression levels in NFH (n = 96) vs DFH (n = 96) patients. D , E Correlation analyses between VEGFA and miR-141-3p or DLX6-AS1 (n = 96). Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA. hBMSCs, Human bone marrow mesenchymal stem cells. NFH, normal fracture healing; DFH, delayed fracture healing. ** P < 0.01, *** P < 0.001
    Figure Legend Snippet: VEGFA is a binding target of miR-141-3p. A Predicted binding sequence. B Dual-luciferase assay validation. C VEGFA expression levels in NFH (n = 96) vs DFH (n = 96) patients. D , E Correlation analyses between VEGFA and miR-141-3p or DLX6-AS1 (n = 96). Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA. hBMSCs, Human bone marrow mesenchymal stem cells. NFH, normal fracture healing; DFH, delayed fracture healing. ** P < 0.01, *** P < 0.001

    Techniques Used: Binding Assay, Sequencing, Luciferase, Biomarker Discovery, Expressing

    Functional role of the miR-141-3p/VEGFA axis in hBMSCs. A miR-141-3p and VEGFA abundance after transfection. B Proliferation assessed. C Apoptosis analysis. D Expression of chondrogenic differentiation markers after indicated treatments. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow mesenchymal stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001
    Figure Legend Snippet: Functional role of the miR-141-3p/VEGFA axis in hBMSCs. A miR-141-3p and VEGFA abundance after transfection. B Proliferation assessed. C Apoptosis analysis. D Expression of chondrogenic differentiation markers after indicated treatments. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow mesenchymal stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001

    Techniques Used: Functional Assay, Transfection, Expressing



    Similar Products

    human bone marrow mesenchymal stem cells hbmscs  (ATCC)
    96
    ATCC human bone marrow mesenchymal stem cells hbmscs
    Interaction between DLX6-AS1 and miR-141-3p. A Predicted target sites. B Dual-luciferase reporter validation of the interaction. C Correlation analysis of serum DLX6-AS1 and miR-141-3p levels. D , E Expression of chondrogenic differentiation markers D , DLX6-AS1, and miR-141-3p E during <t>hBMSCs</t> chondrogenic differentiation. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow <t>mesenchymal</t> stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001
    Human Bone Marrow Mesenchymal Stem Cells Hbmscs, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone marrow mesenchymal stem cells hbmscs/product/ATCC
    Average 96 stars, based on 1 article reviews
    human bone marrow mesenchymal stem cells hbmscs - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    mesenchymal stem cells hbmscs  (ATCC)
    96
    ATCC mesenchymal stem cells hbmscs
    Interaction between DLX6-AS1 and miR-141-3p. A Predicted target sites. B Dual-luciferase reporter validation of the interaction. C Correlation analysis of serum DLX6-AS1 and miR-141-3p levels. D , E Expression of chondrogenic differentiation markers D , DLX6-AS1, and miR-141-3p E during <t>hBMSCs</t> chondrogenic differentiation. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow <t>mesenchymal</t> stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001
    Mesenchymal Stem Cells Hbmscs, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mesenchymal stem cells hbmscs/product/ATCC
    Average 96 stars, based on 1 article reviews
    mesenchymal stem cells hbmscs - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    hbmscs  (ATCC)
    96
    ATCC hbmscs
    Interaction between DLX6-AS1 and miR-141-3p. A Predicted target sites. B Dual-luciferase reporter validation of the interaction. C Correlation analysis of serum DLX6-AS1 and miR-141-3p levels. D , E Expression of chondrogenic differentiation markers D , DLX6-AS1, and miR-141-3p E during <t>hBMSCs</t> chondrogenic differentiation. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow <t>mesenchymal</t> stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001
    Hbmscs, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hbmscs/product/ATCC
    Average 96 stars, based on 1 article reviews
    hbmscs - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    human bone marrow mesenchymal stem cells hbmscs  (ScienCell)
    90
    ScienCell human bone marrow mesenchymal stem cells hbmscs
    Interaction between DLX6-AS1 and miR-141-3p. A Predicted target sites. B Dual-luciferase reporter validation of the interaction. C Correlation analysis of serum DLX6-AS1 and miR-141-3p levels. D , E Expression of chondrogenic differentiation markers D , DLX6-AS1, and miR-141-3p E during <t>hBMSCs</t> chondrogenic differentiation. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow <t>mesenchymal</t> stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001
    Human Bone Marrow Mesenchymal Stem Cells Hbmscs, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone marrow mesenchymal stem cells hbmscs/product/ScienCell
    Average 90 stars, based on 1 article reviews
    human bone marrow mesenchymal stem cells hbmscs - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    human bone marrow mesenchymal stem cells (hbmsc)  (Cyagen Biosciences)
    90
    Cyagen Biosciences human bone marrow mesenchymal stem cells (hbmsc)
    Interaction between DLX6-AS1 and miR-141-3p. A Predicted target sites. B Dual-luciferase reporter validation of the interaction. C Correlation analysis of serum DLX6-AS1 and miR-141-3p levels. D , E Expression of chondrogenic differentiation markers D , DLX6-AS1, and miR-141-3p E during <t>hBMSCs</t> chondrogenic differentiation. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow <t>mesenchymal</t> stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001
    Human Bone Marrow Mesenchymal Stem Cells (Hbmsc), supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone marrow mesenchymal stem cells (hbmsc)/product/Cyagen Biosciences
    Average 90 stars, based on 1 article reviews
    human bone marrow mesenchymal stem cells (hbmsc) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Interaction between DLX6-AS1 and miR-141-3p. A Predicted target sites. B Dual-luciferase reporter validation of the interaction. C Correlation analysis of serum DLX6-AS1 and miR-141-3p levels. D , E Expression of chondrogenic differentiation markers D , DLX6-AS1, and miR-141-3p E during hBMSCs chondrogenic differentiation. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow mesenchymal stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001

    Journal: Journal of Orthopaedic Surgery and Research

    Article Title: Serum DLX6-AS1 and miR-141-3p as early diagnostic biomarkers and regulators of delayed fracture healing (DFH)

    doi: 10.1186/s13018-025-06478-5

    Figure Lengend Snippet: Interaction between DLX6-AS1 and miR-141-3p. A Predicted target sites. B Dual-luciferase reporter validation of the interaction. C Correlation analysis of serum DLX6-AS1 and miR-141-3p levels. D , E Expression of chondrogenic differentiation markers D , DLX6-AS1, and miR-141-3p E during hBMSCs chondrogenic differentiation. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow mesenchymal stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001

    Article Snippet: Human bone marrow mesenchymal stem cells (hBMSCs) were obtained from ATCC (USA).

    Techniques: Luciferase, Biomarker Discovery, Expressing

    Effect of DLX6-AS1/miR-141-3p on hBMSCs functions. A qRT-PCR analysis of DLX6-AS1 and miR-141-3p after si-DLX6-AS1 treatment with or without miR-inhibition. B Proliferation level. C Apoptosis rate. D Expression of chondrogenic differentiation markers SOX9, COL2A1, and ACAN. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow mesenchymal stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001

    Journal: Journal of Orthopaedic Surgery and Research

    Article Title: Serum DLX6-AS1 and miR-141-3p as early diagnostic biomarkers and regulators of delayed fracture healing (DFH)

    doi: 10.1186/s13018-025-06478-5

    Figure Lengend Snippet: Effect of DLX6-AS1/miR-141-3p on hBMSCs functions. A qRT-PCR analysis of DLX6-AS1 and miR-141-3p after si-DLX6-AS1 treatment with or without miR-inhibition. B Proliferation level. C Apoptosis rate. D Expression of chondrogenic differentiation markers SOX9, COL2A1, and ACAN. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow mesenchymal stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001

    Article Snippet: Human bone marrow mesenchymal stem cells (hBMSCs) were obtained from ATCC (USA).

    Techniques: Quantitative RT-PCR, Inhibition, Expressing

    VEGFA is a binding target of miR-141-3p. A Predicted binding sequence. B Dual-luciferase assay validation. C VEGFA expression levels in NFH (n = 96) vs DFH (n = 96) patients. D , E Correlation analyses between VEGFA and miR-141-3p or DLX6-AS1 (n = 96). Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA. hBMSCs, Human bone marrow mesenchymal stem cells. NFH, normal fracture healing; DFH, delayed fracture healing. ** P < 0.01, *** P < 0.001

    Journal: Journal of Orthopaedic Surgery and Research

    Article Title: Serum DLX6-AS1 and miR-141-3p as early diagnostic biomarkers and regulators of delayed fracture healing (DFH)

    doi: 10.1186/s13018-025-06478-5

    Figure Lengend Snippet: VEGFA is a binding target of miR-141-3p. A Predicted binding sequence. B Dual-luciferase assay validation. C VEGFA expression levels in NFH (n = 96) vs DFH (n = 96) patients. D , E Correlation analyses between VEGFA and miR-141-3p or DLX6-AS1 (n = 96). Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA. hBMSCs, Human bone marrow mesenchymal stem cells. NFH, normal fracture healing; DFH, delayed fracture healing. ** P < 0.01, *** P < 0.001

    Article Snippet: Human bone marrow mesenchymal stem cells (hBMSCs) were obtained from ATCC (USA).

    Techniques: Binding Assay, Sequencing, Luciferase, Biomarker Discovery, Expressing

    Functional role of the miR-141-3p/VEGFA axis in hBMSCs. A miR-141-3p and VEGFA abundance after transfection. B Proliferation assessed. C Apoptosis analysis. D Expression of chondrogenic differentiation markers after indicated treatments. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow mesenchymal stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001

    Journal: Journal of Orthopaedic Surgery and Research

    Article Title: Serum DLX6-AS1 and miR-141-3p as early diagnostic biomarkers and regulators of delayed fracture healing (DFH)

    doi: 10.1186/s13018-025-06478-5

    Figure Lengend Snippet: Functional role of the miR-141-3p/VEGFA axis in hBMSCs. A miR-141-3p and VEGFA abundance after transfection. B Proliferation assessed. C Apoptosis analysis. D Expression of chondrogenic differentiation markers after indicated treatments. Data are presented as mean ± SD. Statistical analysis was performed using Student’s t-test or one-way ANOVA (n = 3). hBMSCs, Human bone marrow mesenchymal stem cells. * P < 0.05, ** P < 0.01, *** P < 0.001

    Article Snippet: Human bone marrow mesenchymal stem cells (hBMSCs) were obtained from ATCC (USA).

    Techniques: Functional Assay, Transfection, Expressing